TRAMONTANO, ENZO
 Distribuzione geografica
Continente #
EU - Europa 418.428
NA - Nord America 19.434
AS - Asia 9.276
SA - Sud America 1.448
AF - Africa 300
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 14
Totale 448.924
Nazione #
IT - Italia 413.584
US - Stati Uniti d'America 19.107
SG - Singapore 3.604
CN - Cina 3.027
SE - Svezia 1.188
BR - Brasile 1.098
UA - Ucraina 969
VN - Vietnam 893
DE - Germania 614
FI - Finlandia 570
GB - Regno Unito 468
FR - Francia 426
HK - Hong Kong 334
IN - India 237
BD - Bangladesh 224
KR - Corea 172
CA - Canada 169
AR - Argentina 139
NL - Olanda 123
TR - Turchia 101
MX - Messico 99
IQ - Iraq 95
JP - Giappone 93
MA - Marocco 93
AT - Austria 79
PL - Polonia 75
RU - Federazione Russa 71
ZA - Sudafrica 70
PK - Pakistan 68
EC - Ecuador 59
ID - Indonesia 57
ES - Italia 49
CO - Colombia 39
SA - Arabia Saudita 39
IR - Iran 37
BE - Belgio 36
PH - Filippine 33
VE - Venezuela 33
UZ - Uzbekistan 31
IE - Irlanda 26
TN - Tunisia 25
IL - Israele 23
AE - Emirati Arabi Uniti 22
CZ - Repubblica Ceca 21
KE - Kenya 21
AU - Australia 20
CL - Cile 20
AZ - Azerbaigian 19
EG - Egitto 19
JO - Giordania 19
PY - Paraguay 18
MY - Malesia 17
TW - Taiwan 17
NP - Nepal 16
PT - Portogallo 15
BO - Bolivia 14
DZ - Algeria 14
ET - Etiopia 14
LT - Lituania 13
UY - Uruguay 13
DK - Danimarca 12
EU - Europa 11
GE - Georgia 11
JM - Giamaica 11
KG - Kirghizistan 11
OM - Oman 11
PE - Perù 11
CH - Svizzera 10
GR - Grecia 10
LB - Libano 9
NO - Norvegia 9
CR - Costa Rica 8
KZ - Kazakistan 8
LV - Lettonia 8
QA - Qatar 8
RO - Romania 8
HU - Ungheria 7
PA - Panama 7
TH - Thailandia 7
HN - Honduras 6
MU - Mauritius 6
NG - Nigeria 6
SK - Slovacchia (Repubblica Slovacca) 6
AL - Albania 5
BG - Bulgaria 5
DO - Repubblica Dominicana 5
GT - Guatemala 5
HR - Croazia 5
SY - Repubblica araba siriana 5
AM - Armenia 4
CI - Costa d'Avorio 4
KH - Cambogia 4
MN - Mongolia 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
BW - Botswana 3
Totale 448.862
Città #
Cagliari 402.067
Uta 9.931
Singapore 1.966
Ashburn 1.900
Fairfield 1.590
Woodbridge 1.321
San Jose 1.190
Dallas 1.013
Chandler 993
Boardman 911
Houston 829
Nyköping 727
Seattle 661
Wilmington 647
Ann Arbor 561
Beijing 561
Cambridge 550
Jacksonville 475
Los Angeles 412
Council Bluffs 400
New York 380
Helsinki 373
Dearborn 349
Santa Clara 284
Hong Kong 282
Lauterbourg 245
Ho Chi Minh City 236
Shanghai 233
Hefei 222
The Dalles 212
Boston 197
Nanjing 186
Hanoi 174
Dong Ket 170
Seoul 151
Buffalo 146
Milan 113
Rome 113
San Diego 108
São Paulo 102
Chicago 99
Munich 91
Redwood City 88
Guangzhou 79
Tokyo 73
Herndon 71
Nanchang 68
London 64
Orem 64
Phoenix 63
Redondo Beach 63
Toronto 62
Changsha 60
Warsaw 59
Atlanta 57
Casablanca 57
Tianjin 57
Frankfurt am Main 55
Amsterdam 54
Mountain View 53
Shenyang 53
Vienna 52
Hangzhou 49
Washington 44
Brooklyn 43
Jiaxing 43
Rio de Janeiro 42
Sassari 42
Verona 42
Nuremberg 40
Columbus 38
Hebei 38
Lappeenranta 38
Mexico City 36
Da Nang 35
San Francisco 35
Baghdad 34
Wuhan 34
Montreal 33
Redmond 33
Chennai 32
Istanbul 32
Stockholm 32
Denver 31
Mumbai 29
Norwalk 29
Salt Lake City 29
Tashkent 28
Jinan 26
Guayaquil 25
Manchester 25
Brasília 24
Brussels 24
Curitiba 24
Haiphong 24
Zhengzhou 24
Birmingham 23
Dublin 23
Poplar 23
Johannesburg 22
Totale 435.651
Nome #
Comparing the responses of countries and National Health Systems to the COVID-19 pandemic: a critical analysis with a case-report series 20.836
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro- 1H -indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 14.730
Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase 4.691
Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase 4.533
Quercetin blocks Ebola Virus infection by counteracting the VP24 Interferon inhibitory function 4.482
Biological activities of aerial parts extracts of Euphorbia characias 4.445
Ribonuclease H/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6 4.332
Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase 4.192
Identification of Myricetin as Ebolavirus VP35-dsRNA interaction inhibitor through a novel fluorescence-based assay 3.757
Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 Reverse transcriptase-associated RNase H and RDDP functions 3.519
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 3.492
Uvaria angolensis as a promising source of inhibitors of HIV-1 RT-associated RNA-dependent DNA polymerase and RNase H functions 3.463
Dual HIV-1 reverse transcriptase and integrase inhibitors from Limonium morisianum Arrigoni, an endemic species of Sardinia (Italy) 3.449
Sennoside A, derived from the traditional chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication 3.435
Onopordum illyricum L.: new anti HIV-1 agents from a Mediterranean edible plant 3.415
Broad-range potential of Asphodelus microcarpus leaves extract for drug development 3.375
Design and synthesis of new isatin derivatives as HIV-1 reverse transcriptase associated ribonuclease H inhibitors 3.354
Molecular Aspects of the RT/drug Interactions. Perspective of Dual Inhibitors 3.316
Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors 3.313
Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action 3.300
Insights into the homo-oligomerization properties of N-terminal coiled-coil domain of Ebola virus VP35 protein 3.279
Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors 3.108
Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques 3.102
Inhibition of HIV-1 reverse transcriptase dimerization by small molecules 3.081
Prenylated phloroglucinols from Hypericum scruglii, an endemic species of Sardinia (Italy), as new dual HIV-1 inhibitors effective on HIV-1 replication 3.053
Relevance of Ebola virus VP35 homo-dimerization on the type I interferon cascade inhibition 3.053
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Dual Inhibitors of HIV-1 RT. 3.043
Onopordum illyricum L., a Mediterranean plant, as a source of anti HIV-1 compounds 3.006
Insights into Ebola Virus VP35 and VP24 Interferon inhibitory functions and their initial exploitation as drug targets 3.002
Purification and characterization of DR_2577 (SlpA) a major S-layer protein from Deinococcus radiodurans 2.969
Preliminary study of endemic plants of Sardinia as a source of new antiviral agents 2.935
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Single Site Dual Inhibitors of HIV-1 RT 2.933
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) shed light on the mechanism of action of a new Ribonuclease H/ DNA polymerase RT dual inhibitor 2.922
From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors 2.921
Structure-guided approach identifies a novel class of HIV-1 Ribonuclease H inhibitors: Binding mode insights through magnesium complexation and site-directed mutagenesis studies 2.888
Chelation motifs affecting metal-dependent viral enzymes: N′-acylhydrazone ligands as dual target inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H domain 2.879
Hypericum hircinum L. components as new single-molecule inhibitors of both HIV-1 reverse transcriptase-associated DNA polymerase and ribonuclease H activities 2.876
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 2.867
On the S-layer of Thermus thermophilus and the assembling of its main protein SIpA 2.849
The S-layer protein DR_2577 binds deinoxanthin and under desiccation conditions protects against UV-radiation in Deinococcus radiodurans 2.845
Natural Product Kuwanon-L Inhibits HIV-1 Replication through Multiple Target Binding 2.831
Insights into Ebola VP35 oligomerization from molecular simulations 2.818
Development and validation of a novel dual luciferase reporter gene assay to quantify Ebola virus VP24 inhibition of IFN signaling 2.789
Mutagenic study on HIV-1 reverse transcriptase to explore the mechanism of action of HIV-1 reverse transcriptase dual inhibitors 2.776
Intracellular human antibody fragments recognizing the VP35 protein of Zaire Ebola filovirus inhibit the protein activity 2.770
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity 2.736
null 2.719
New insights into the interaction between pyrrolyl diketoacids and HIV-1 integrase active site and comparison with RNase H 2.713
ANALYSIS OF 98 HERV-K(HML-2) CONTAINING PROVIRUSES IDENTIFIED IN THE HUMAN GENOME ASSEMBLY GRCH37/HG19 BY RETROTECTOR AND THEIR GENOMIC CONTEXT 2.707
Synthesis and biological activity evaluation of new dual-inhibitors of both associated functions of HIV-1 RT 2.659
Active site and allosteric inhibitors of the ribonuclease H activity of HIV reverse transcriptase 2.640
3-[2-(4-aryl-1,3-thiazol-2-yl)hydrazin-1-ylidene]-1H-indol-2-ones as new potential dual inhibitors of polimerase and ribonuclease HIV-1 RT associated function 2.621
Towards the total block of HIV-1 Reverse Transcriptase: the dual-inhibitors approach 2.614
Identification of a novel HERV-K(HML10): comprehensive characterization and comparative analysis in non-human primates provide insights about HML10 proviruses structure and diffusion 2.577
Use of a Dual Luciferase Cell-Based Drug Screening Assay to Study VP24 Inhibition of JAK/STAT Pathway and its Reversion by Compounds 2.574
Investigation on the mechanism of action of new dual inhibitors of HIV-1 RT 2.554
Classification and characterization of human endogenous retroviruses; mosaic forms are common 2.551
Contribution of type W human endogenous retroviruses to the human genome: Characterization of HERV-W proviral insertions and processed pseudogenes 2.489
Human Endogenous Retrovirus type W distribution in the human genome: identification and characterization of a new set of proviral sequences in GRCh37/hg19 assembly 2.479
Chalcones as novel dual inhibitors of HIV-1 reverse transcriptase 2.465
New dual inhibitors of RT associated functions: investigation on their mechanism and mode of action 2.458
Meeting report: Fourth Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS) 2.441
Integration of SARS-CoV-2 RNA in infected human cells by retrotransposons: an unlikely hypothesis and old viral relationships 2.435
Structure-Activity Relationship of Pyrrolyl Diketo Acid Derivatives as Dual Inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H Domain 2.432
Inhibition of HIV-1 reverse transcriptase associated activities by the hydroalcoholic extract of Casimiroa edulis seeds 2.426
Validation of a computed radiography device to monitor the HIV-1 RNase H activity 2.410
An efficient route to novel uracil-based drug-like molecules 2.372
Inhibitory effect of 2,3,5,6-tetrafluoro-4-[4-(Aryl)-1H-1,2,3-triazol-1-yl]benzenesulfonamide derivatives on HIV reverse transcriptase associated rnase H activities 2.364
Improvement of the activity of the anti-HIV-1 integrase aptamer T30175 by introducing a modified thymidine into the loops 2.347
null 2.329
Identification and genomic characterization of HERV-K (HML-10) in human genome GRCh37/hg19 assembly 2.324
A Luciferase Reporter Gene Assay to Measure Ebola Virus Viral Protein 35–Associated Inhibition of Double-Stranded RNA–Stimulated, Retinoic Acid–Inducible Gene 1–Mediated Induction of Interferon β 2.317
Exploring new scaffolds for the inibition of the Ribonuclease H function of RT HIV-1 2.273
2-(Arylamino)-6-(trifluoromethyl)nicotinic Acid Derivatives: New HIV-1 RT Dual Inhibitors Active on Viral Replication 2.262
HERV-W group evolutionary history in non-human primates: Characterization of ERV-W orthologs in Catarrhini and related ERV groups in Platyrrhini 2.258
1,2,4-Triazolo[1,5-a]pyrimidines as a Novel Class of Inhibitors of the HIV-1 Reverse Transcriptase-Associated Ribonuclease H Activity 2.231
Development and identification of a novel anti-HIV-1 peptide derived by modification of the N-terminal domain of HIV-1 integrase 2.224
Investigation on the sucrose binding pocket of HIV-1 Integrase by molecular dynamics and synergy experiments 2.221
Design and synthesis of new Isatin derivatives as HIV-1 Reverse Transcriptase associated Ribonuclease H inhibitors twenty-fourth 2.157
Isatin derivatives as new scaffolds for HIV-1 reverse transcriptase associated RNase H and RDDP dual inhibitors 2.151
Discovery of dihydroxyindole-2-carboxylic acid derivatives as dual allosteric HIV-1 Integrase and Reverse Transcriptase associated Ribonuclease H inhibitors 2.135
Human endogenous retroviruses are ancient acquired elements still shaping innate immune responses 2.120
Meeting report: Third Summer School on innovative approaches for identification of antiviral agents (IAAASS) 2.116
Alizarine derivatives as new dual inhibitors of the HIV-1 reverse transcriptase-associated DNA polymerase and RNase H activities effective also on the RNase H activity of non-nucleoside resistant reverse transcriptases 2.113
Targeting HIV-1 RNase H: N'-(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants 2.112
Design, synthesis and biolgical activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 2.091
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 2.084
Kuwanon-L as a new allosteric HIV-1 integrase inhibitor: molecular modeling and biological evaluation 2.079
New features of the cell wall of the radio-resistant bacterium Deinococcus radiodurans 2.065
Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus 2.065
Ebola virus VP35 blocks stress granule assembly 2.047
6-(1-Benzyl-1H-pyrrol-2-yl)-2,4-dioxo-5-hexenoic acids as dual inhibitors of recombinant HIV-1 integrase and ribonuclease H, synthesized by a parallel synthesis approach 2.045
HERV envelope proteins: Physiological role and pathogenic potential in cancer and autoimmunity 2.041
Type W Human Endogenous Retrovirus (HERV-W) Integrations and Their Mobilization by L1 Machinery: Contribution to the Human Transcriptome and Impact on the Host Physiopathology 2.016
Design, synthesis and biological activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 1.979
Comprehensive Characterization of the Human Endogenous Retrovirus HERV-K(HML-6) Group: Overview of Structure, Phylogeny, and Contribution to the Human Genome 1.965
Identification of HIV-1 reverse trascriptase dual inhibitors by a combined shape-, 2D fingerprint and pharmacophore-based virtual screening approch 1.932
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action 1.890
Design of new inhibitors of the HIV-1 Reverse Transcriptase associated Ribonuclease H function: a synthetic approach 1.889
Pyrrolyl Pyrazoles as Non-Diketo Acid Inhibitors of the HIV-1 Ribonuclease H Function of Reverse Transcriptase 1.881
Totale 303.219
Categoria #
all - tutte 556.425
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 556.425


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.523 0 0 0 0 0 0 0 0 0 0 0 2.523
2021/202223.462 2.379 1.875 1.195 1.419 1.852 1.786 1.324 1.202 2.274 2.345 2.865 2.946
2022/202340.300 3.440 5.633 4.589 3.519 2.514 4.377 1.973 3.178 2.117 2.391 3.242 3.327
2023/202438.637 2.373 1.373 2.010 3.476 3.722 6.385 5.038 3.012 1.887 2.286 3.411 3.664
2024/202591.439 15.305 41.501 10.614 7.743 3.619 4.266 5.061 362 795 596 716 861
2025/202621.113 1.402 681 2.392 1.934 1.762 1.440 3.572 1.903 1.418 2.387 1.453 769
Totale 449.905